Literature DB >> 9870037

The role of human papillomaviruses in anogenital cancers.

M Melbye1, M Frisch.   

Abstract

There is substantial evidence to suggest that common risk factors exist for cancer of the cervix and other anogenital cancers. Cervical cancer has been etiologically linked with venereal types of human papillomavirus (HPV) and the same types of HPV are being found in other anogenital tissues. The question is to what extent these HPV types may also contribute to carcinogenesis in anogenital cancer other than cervical cancer. In this review some general aspects of the natural history of HPV are presented followed by a description of the incidence and risk factors for anal, vulvar, and penile cancer. Main focus is given to the evidence for an association between these cancers and HPV.

Entities:  

Mesh:

Year:  1998        PMID: 9870037     DOI: 10.1006/scbi.1998.0081

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  12 in total

1.  PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum.

Authors:  I C Le Poole; R E Boissy; R Sarangarajan; J Chen; J J Forristal; P Sheth; W Westerhof; G Babcock; P K Das; C B Saelinger
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-05       Impact factor: 2.416

2.  Detection of human papillomavirus DNA in pterygia from different geographical regions.

Authors:  F Piras; P S Moore; J Ugalde; M T Perra; A Scarpa; P Sirigu
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

3.  Race and prevalence of human papillomavirus infection among men residing in Brazil, Mexico and the United States.

Authors:  Gabriel O Akogbe; Abidemi Ajidahun; Bradley Sirak; Gabriella M Anic; Mary R Papenfuss; William J Fulp; Hui-Yi Lin; Martha Abrahamsen; Luisa L Villa; Eduardo Lazcano-Ponce; Manuel Quiterio; Danelle Smith; Matthew B Schabath; Jorge Salmeron; Anna R Giuliano
Journal:  Int J Cancer       Date:  2012-01-11       Impact factor: 7.396

4.  Socio-Demographic, Reproductive and Clinical Profile of Women Diagnosed with Advanced Cervical Cancer in a Tertiary Care Institute of Delhi.

Authors:  Neha Dahiya; Damodar Bachani; Anita S Acharya; D N Sharma; Subhash Gupta; K P Haresh
Journal:  J Obstet Gynaecol India       Date:  2016-06-13

5.  Factors Associated with Pre- and Post-Educational Intervention Knowledge Levels of HPV and Cervical Cancer Among the Male and Female University Students, Northwest Ethiopia.

Authors:  Meera Indracanti; Nega Berhane; Tigist Minyamer
Journal:  Cancer Manag Res       Date:  2021-09-14       Impact factor: 3.989

6.  Efficacy of trichloroacetic acid in the treatment of anal intraepithelial neoplasia in HIV-positive and HIV-negative men who have sex with men.

Authors:  Jasmeet Chadha Singh; Victoria Kuohung; Joel M Palefsky
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12-01       Impact factor: 3.731

7.  Understanding the burden of human papillomavirus-associated anal cancers in the US.

Authors:  Djenaba A Joseph; Jacqueline W Miller; Xiaocheng Wu; Vivien W Chen; Cyllene R Morris; Marc T Goodman; Jose M Villalon-Gomez; Melanie A Williams; Rosemary D Cress
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

8.  Changing patterns of anal canal carcinoma in the United States.

Authors:  Rebecca A Nelson; Alexandra M Levine; Leslie Bernstein; David D Smith; Lily L Lai
Journal:  J Clin Oncol       Date:  2013-03-18       Impact factor: 44.544

Review 9.  Telomeres and telomere dynamics: relevance to cancers of the GI tract.

Authors:  Nivedita Basu; Halcyon G Skinner; Kristin Litzelman; Russell Vanderboom; Esha Baichoo; Lisa A Boardman
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2013-11       Impact factor: 3.869

10.  Impact of radiotherapy duration on overall survival in squamous cell carcinoma of the anus.

Authors:  Shahil Mehta; Stephen J Ramey; Deukwoo Kwon; Benjamin J Rich; Awad A Ahmed; Aaron Wolfson; Raphael Yechieli; Lorraine Portelance; Eric A Mellon
Journal:  J Gastrointest Oncol       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.